Pertuzumab Plus Trastuzumab Surpasses Prespecified Activity

Pertuzumab Plus Trastuzumab Surpasses Prespecified Activity Threshold in ERBB2/3-Altered Biliary Tract Cancer

Pertuzumab Plus Trastuzumab Surpasses Prespecified Activity Threshold in ERBB2/3-Altered Biliary Tract Cancer

onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Memorial Sloan Kettering Cancer Center , New York , American , Cathy Eng , Eileenm Oreilly , Vanderbilt Ingram Cancer Center , National Comprehensive Cancer Network Guidelines , Drug Administration , Gastrointestinal Cancer Program At Inova , Gastrointestinal Cancer Program , African American , Editor Eileen ,